Snowball Effect

Call Directions Website Contact the business

Snowball Effect Snowball Effect is an investment platform that simplifies access to managed funds and companies.

Snowball Effect is a private equity and managed fund investment platform in New Zealand.

WHOLESALE INVESTORS: A limited opportunity to invest in TheiaNova, one of NZ’s globally recognised biotech companies.The...
15/09/2026

WHOLESALE INVESTORS: A limited opportunity to invest in TheiaNova, one of NZ’s globally recognised biotech companies.

TheiaNova is developing a breakthrough patented regenerative treatment for keratoconus (an eye disease with no cure) that affects over 23.7 million people globally.

The company targets an estimated US$5B addressable market in keratoconus, with an additional US$3 to $5B across adjacent indications like post-refractive ectasia.

TheiaNova is raising capital to fund essential safety studies required for US regulatory submission.

Register your interest to learn more: https://www.snowballeffect.co.nz/offers/show/theianova-n24vp

Orbis Diagnostics CEO Cather Simpson recently sat down with BusinessDesk NZ to discuss the company's ambitions to transf...
26/08/2026

Orbis Diagnostics CEO Cather Simpson recently sat down with BusinessDesk NZ to discuss the company's ambitions to transform medical testing.

From tackling Hepatitis B to its plans for the US market, Cather shares why Orbis has focused on de-risking the commercial and regulatory sides of the business early on.

Read the BusinessDesk article here (paywall): https://businessdesk.co.nz/article/startups/orbis-ceo-early-commercial-derisking-is-key-to-med-tech-companies-success

Orbis is currently raising capital via Snowball. To learn more about investing in Orbis, see: https://www.snowballeffect.co.nz/offers/show/orbis-diagnostics-2026-f0qgh

WHOLESALE INVESTMENT: Over 23M people worldwide live with keratoconus, a debilitating eye disease for which there is no ...
25/08/2026

WHOLESALE INVESTMENT: Over 23M people worldwide live with keratoconus, a debilitating eye disease for which there is no cure.

TheiaNova, a NZ biopharmaceutical company, is developing a regenerative eye drop designed to halt disease progression and preserve vision, and is raising capital to fund essential further work and clinical trials.

Leading investors, including Bridgewest Ventures, have already committed over $1M to TheiaNova's capital raise.

Will you be joining them?

Learn more about investing in TheiaNova here: https://www.snowballeffect.co.nz/offers/preview/theianova-0bojx

REEFTON RAISE: Nearly $1M raised to date!It’s great to see Kiwi investors getting behind the iconic West Coast distiller...
24/08/2026

REEFTON RAISE: Nearly $1M raised to date!

It’s great to see Kiwi investors getting behind the iconic West Coast distillery, Reefton Distilling Co.

Known for its award-winning fine spirits, Reefton Distilling Co. is raising capital to fund the next phase of company-owned whisky production.

The investment offer closes soon.

Tap the link to learn more about Reefton and how you can invest: https://www.snowballeffect.co.nz/offers/show/reefton-distilling-co-2026-vkh02-d7ZFK

What if AI could detect livestock disease before farmers can?MACSO has developed AI-powered sensor technology designed t...
11/08/2026

What if AI could detect livestock disease before farmers can?

MACSO has developed AI-powered sensor technology designed to detect respiratory disease in swine up to six days earlier than trained human operators.​

This not only reduces mortality rates​ but also provides a return on investment of up to 12x for commercial swine producers.

​M​ACSO has secured multi-year distribution valued at US​D 55​M and is now raising additional capital to execute on that distribution and accelerate international growth.

Learn more about investing in MACSO through Snowball: https://www.snowballeffect.co.nz/offers/preview/macso-technologies-2026-yxc5y

Minimum investment of $5,000.

ORBIS RAISE: Over $6M committed in investment so far!It’s fantastic to see so many NZ investors back Orbis Diagnostics a...
06/08/2026

ORBIS RAISE: Over $6M committed in investment so far!

It’s fantastic to see so many NZ investors back Orbis Diagnostics and its mission to develop a blood-testing platform that delivers rapid, laboratory-quality diagnostic results within 30 minutes.

Tap the link to learn more about Orbis and how you can invest via Snowball's investment platform: https://www.snowballeffect.co.nz/offers/show/orbis-diagnostics-2026-f0qgh

NEW INVESTMENT OFFER: From the heart of NZ's rugged West Coast comes Reefton Distilling Co., with its Little Biddy brand...
20/07/2026

NEW INVESTMENT OFFER: From the heart of NZ's rugged West Coast comes Reefton Distilling Co., with its Little Biddy brand, the number one fastest-growing premium NZ spirits brand in the country.

B Corp Certified and with over 125 awards, the distillery's spirits are so good that it secured a multi-year bulk spirit supply agreement with Scotland’s Scotch Malt Whisky Society.

Now investors have the opportunity to become part of Reefton Distilling Co.​'s next chapter​ as it raises up to $2M to continue to grow its whisky inventory.

Tap the link to learn more and register your interest: https://www.snowballeffect.co.nz/offers/preview/reefton-distilling-co-2026-q90u6-rDDLx

BioOra's current capital raise is closing soon, with nearly $10.5M already committed. If you're curious about learning m...
08/07/2026

BioOra's current capital raise is closing soon, with nearly $10.5M already committed.

If you're curious about learning more about BioOra, listen to BioOra CEO John Robson's podcast interview linked below. In the episode, he shares more about BioOra's mission to democratise CAR T-cell therapy for cancer patients.

➡ Listen via Spotify: https://open.spotify.com/episode/0K1CLN84WE25NCaq7HcmST?si=f3d7ced2c25245ac&nd=1&dlsi=e3651db985c34e68

➡ Listen via Apple: https://podcasts.apple.com/us/podcast/high-conviction-patient-61-and-the-future-of-car/id1884128954?i=1000761974388

NEW INVESTMENT OPPORTUNITY: 70% of medical decisions rely on lab test results, yet patients can wait days for results to...
22/06/2026

NEW INVESTMENT OPPORTUNITY: 70% of medical decisions rely on lab test results, yet patients can wait days for results to be processed and returned.

Orbis Diagnostics is developing a next-generation diagnostic platform designed to deliver lab-quality blood test results from a minimal blood sample, directly at the point of care.

The goal? Faster diagnosis, faster treatment, and improved healthcare outcomes.

Orbis is now opening its Pre-Series A round for retail investors via Snowball.

➡️ Take a look: https://www.snowballeffect.co.nz/offers/preview/orbis-diagnostics-2026-tprjy

Please read all offer materials, as investing can be high-risk.

INVEST IN BIOORA: Every year, ~1,000 Kiwis are diagnosed with hard-to-treat lymphoma, and most can't access the CAR-T th...
19/05/2026

INVEST IN BIOORA: Every year, ~1,000 Kiwis are diagnosed with hard-to-treat lymphoma, and most can't access the CAR-T therapy that could save their lives.

BioOra, in partnership with the Malaghan Institute, is developing NZ’s first manufacturing capability for novel third-generation CAR T-cell therapies - that reprogram immune cells to find and destroy cancer.

Tap the link to learn how you can support BioOra’s life-changing work: https://www.snowballeffect.co.nz/offers/preview/bioora-prvw-825aug-jk9gN

Address

1 Faraday Street, Parnell
Auckland
1052

Telephone

+64 9 213 4282

Website

Alerts

Be the first to know and let us send you an email when Snowball Effect posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Snowball Effect:

Shortcuts

Sponsored

Share

Category